Anatara Lifesciences
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WAAnatara Lifesciences (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans.
They are focused on building a pipeline of evidence-based, over-the-counter gastrointestinal health products, through in-house development and in-licencing and distribution opportunities.
Their lead products are Detach for animals and Gastrointestinal Reprogramming dietary supplement for humans.
Contact Details
Level 3, 62 Lygon Street, CARLTON SOUTH VIC 3053
07 3394 8202
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 172nd | Anatara Lifesciences | 99% | -21% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Anatara Lifesciences | $644k |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: John Michailidis, Chief Operating Officer, Executive Director | 10 Jul 2024 |
| NEW ROLE: Simon Erskine, | 08 Jan 2024 |
| NEW ROLE: Nick Haslam, Non-Executive Director | 14 Apr 2023 |
| NEW ROLE: David Brookes, Executive Chair | 13 Apr 2023 |
| NEW ROLE: Dr West, | 03 Jan 2023 |
| NEW ROLE: Michael West, Chief Operating Officer | 24 Nov 2020 |
| NEW ROLE: Tracey Brown, Chief Development Officer | 24 Nov 2020 |
| NEW ROLE: Tracey Mynott, Chief Scientific Officer | 24 Nov 2020 |
| NEW ROLE: Jane Ryan, Non-Executive Director | 03 Nov 2020 |
